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1. Introduction
Although the risk of hypertension for later 
cardiovascular events is well established, it has 
also become clear that this risk is not so impres­
sive for blood pressure levels within the “mild 
hypertension” range. This is even more so when 
other risk factors are lacking. However, better 
insight is necessary into the subgroups of the 
mildly hypertensive population where the risk is 
actually increased, since the potential benefits of 
treatment might be greatest in these groups. In 
daily practice, the work-up of a hypertensive pa­
tient always contains the assessment of a so-called 
risk-profile. Apart form blood pressure, data 
about other well-known cardiovascular risk-fac- 
tors are also collected: smoking habits, body 
weight, glucose and lipids, family predisposition, 
sex and race. A particular place within this as­
sessment is also the detection of eventual signs of 
target organ damage (TOD).
From the Framingham data the extra risk of 
TOD to the heart is well described. What about 
hypertensive TOD in other target organs such as 
cerebrum, kidneys, eyes and peripheral blood 
vessels? One of the pivotal questions in this area 
to be answered is whether TOD in these organs 
can be assessed reliably and at an early stage of
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the hypertension. If so, should the subgroup of 
patients with mild hypertension and with preclini- 
cal TOD be treated more vigorously? What would 
this mean in financial terms and what are the 
potential side-effects of more diagnostic proce­
dures? This would also imply that the appropri­
ate diagnostic methods for this purpose should 
also be available to general physicians. Another 
intriguing issue to be resolved and which is re­
lated to TOD is whether 24-hour ambulator blood 
pressure values are a better predictor of TOD 
than the usual clinic blood pressure values. The 
paper by O’Brien and Coyle in this issue of the 
Journal gives an excellent overview of this topic.
This issue of the Journal concerns the reports 
of a recent symposium on hypertensive TOD. 
Besides oral presentations, a panel discussion was 
held where the practical implications for clini­
cians were discussed. In short, we want to sum­
marize here the conclusions of this discussion and 
the consequences for daily practice as related to 
the different kinds of organ damage.
2. Heart and coronary circulation
As stated above, there is no doubt that the 
presence of hypertensive TOD to the heart in­
creases the risk of cardiac morbidity and mortal­
ity. In particular, the demonstration of left ven­
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tricular hypertrophy (LVH) increases this risk 
considerably. This makes the tracing of hyperten­
sive subjects with LVH necessary. However, the 
sensitivity of the electrocardiogram (ECG) in de­
tecting LVH is very moderate. Moreover, in the 
Dutch guidelines the ECG was optional, since 
ECG equipment is not directly available for most 
general physicians. Echocardiography is superior 
to the ECG for a number of reasons. First, it can 
give a quantitative answer: left ventricular mass 
(LVM) can be calculated and normalized for dif­
ferences in body surface area. The measures of 
posterior wall thickness and interventricular sep­
tal thickness give also more quantitative informa­
tion than the ECG. Second, the echo can deliver 
other specific information e.g., about systolic 
and/or diastolic (dys)function. The latter is often 
disturbed before LVH is even apparent, espe­
cially in elderly subjects. Third, since echocardio­
graphy is just as patient-friendly as the ECG, it 
can be repeated during follow-up by which pro­
gression or regression of LVM and the improve­
ment or worsening of systolic and/or diastolic 
function can be followed. Are there then no 
disadvantages of echocardiography? Of course 
there are: for example, in 10-20% the imaging 
may be insufficient for calculating LVM. These 
problems are more prominent in obese subjects 
and, as known, most hypertensives are at least 
overweight. Other limitations are the time, costs 
and experience needed before accuracy becomes 
sufficient. Even then there remains considerable 
inter- and intra-doctor variation. To perform 
echocardiography in all hypertensive patients 
would mean that general physicians should send 
their patients at least once for echocardiography 
to their local cardiology departments. It is quite 
obvious that this would have wide implications in 
terms of financial costs and for the organization 
of this service.
What are the possible consequences of the 
echocardiographic findings? It may lead to better 
selection of hypertensives who are at greater risk, 
but it should be noted that prospective data are 
still lacking, especially for the early stages. A  
diagnosis of LVH may influence the individual 
cost-benefit balance: e.g., one will decide earlier 
for the addition of an extra drug, or an adverse
reaction will be more easily accepted. Another 
potential consequence of the presence of LVH 
can be the choice of drug. Although in two 
often-cited reviews it is suggested that some 
classes of antihypertensive drugs are superior to 
others with regard to reversal of LVH, most of 
the studies used in the reviews were uncontrolled 
and/or not blinded. In this respect the paper by 
Fagard in this issue clearly shows that if a meta­
analysis is performed with controlled studies only, 
no particular class of antihypertensives has the 
exclusive property of LVH reduction.
There are some other important aspects of the 
relation between hypertension and the heart: e.g., 
the diminished coronary flow reserve or the pres­
ence of subclinical myocardial ischaemia. Al­
though both topics are interesting in terms of 
research as shown in the article by Magrini and 
colleagues in this issue, there have been no direct 
consequences so far for everyday practice,
3. Cerebral and peripheral circulation
After cardiac events, cerebrovascular events 
come second in frequency. Therefore, research 
on the cerebral circulation in hypertension was 
started long ago. The review by Strangaard and 
Paulson in this issue gives an actual impression by 
the most experienced investigators in this field. 
However, their method of measuring cerebral 
blood flow cannot be used in large-scale studies. 
A number of new non-invasive techniques for this 
purpose are now being developed: newer CT- 
scans, MRI or MR-angiography, and near-in­
frared spectroscopy (NIRS) etc. A development 
already more close to clinical practice is that 
developed by and described in this issue by Rene- 
man and Hoeks. It has been developed for the 
study of the distensibility and compliance of the 
carotid artery, e.g. in hypertension. Interesting 
observations demonstrate differences between 
different drugs with regard to the properties of 
the carotid artery wall, but no studies with objec­
tive end-points are presently available. Though 
promising for clinical and fundamental research 
in specialized centres, the method is not available 
for general daily practice.
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Two papers in this issue by Forette et al. about 
vascular dementia and by Lees about stroke 
should motivate all doctors to take an active 
attitude to prevention and to undertake more 
clinical research in this field.
Since the carotid arteries can also be consid­
ered as part of the peripheral circulation, the 
above-mentioned technique of Reneman and 
Hoeks is applicable to other arteries, as is also 
shown by Safavian et al. in this issue. Both groups 
have developed an extensive expertise in this field 
of research and although promising for research 
or use in specialized centres or special patient 
categories, this non-invasive technique is not yet 
available for general clinical practice. This method 
can give new insights into both vascular physiol­
ogy and pharmacology, but its prognostic value as 
a tool for early diagnosis of hypertensive TOD 
has still to be determined.
4. Renal organ damage due to hypertension
The kidney can be the cause of hypertension 
but also the target for damage by hypertension. 
The improvement of antihypertensive treatment 
protects patients from dying from major cerebral 
and cardiac events. Thus an increasing number of 
elderly subjects remain at risk for damage in 
other target organs, e.g. the kidney. The ever 
increasing life expectancy in most western coun­
tries is an additive factor. These factors explain 
that over the last decennium the percentage of 
patients coming to dialysis after longstanding pri­
mary hypertension has risen. Most clinicians will 
follow the course of the kidney function and 
eventual proteinuria at regular intervals in their 
hypertensive patients, but once these parameters 
deteriorate we are too late. In diabetic patients 
the determination of microalbuminuria is an early 
sign of renal damage. For hypertension, with its 
slower deterioration of kidney function, there are 
no data so far that demonstrate that regular 
nephelometric determination of urinary albumin 
excretion has any prognostic value. There may be 
a subgroup where there are indeed arguments 
that it is a cost-effective diagnostic procedure. 
Generally speaking, no strong advice can be given
at present as to whether or not it is useful to 
determine microalbuminuria. Some studies are 
currently underway. The paper by de Leeuw and 
Birkenhâger in this issue gives the pathophysio­
logical background and also discusses the influ­
ence of antihypertensive drugs both as a cause of 
renal function disturbances and as therapy for 
renal damage.
5. Hypertensive retinal damage
The retina is the place where atherosclerosis 
can be observed and followed easily with (almost) 
non-invasive methods. Although the significance 
of fundoscopy for accelerated or malignant hy­
pertension is beyond doubt, the use of retinal 
inspection in subjects who have no malignant or 
accelerated hypertension is questionable. Several 
practical difficulties limit the wide-scale applica­
tion of retinoscopy in all hypertensive subjects: it 
costs time, experience is needed, the more quali­
tative rather than quantitative scoring and the 
disadvantage of mydriasis for the outclinic pa­
tient. Recently there have been some develop­
ments with alternative methods measuring retinal 
atherosclerosis and remodelling in hypertension 
and/or diabetes using standardized retinal pho­
tographs.
6. Conclusions for the clinician
The heart, kidney and cerebral blood vessels 
are still the major target organs for damage by 
hypertension. The assessment and follow-up of 
TOD of these organs should be improved. It 
seems that detection of subgroups of patients 
with only mild hypertension but with subclinical 
or early TOD would be beneficial. More vigorous 
treatment of these subjects might improve the 
clinical outcome in the long term. However, 
prospective studies in this area of extension of 
diagnostic procedures and treatment intensifica­
tion are mandatory in order to justify the un- 
evitable increments in side-effects and financial 
costs. At present, for the clinician measurement 
of renal function and protein excretion and the
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ECG will keep their place despite limitations. 
The implementation of echocardiography for all 
hypertensives will probably be the next develop­
ment for the reasons mentioned above. The value 
of measurements of microalbuminuria, cerebral
blood flow, coronary blood flow reserve, retinal 
imaging and assessment of the properties of the 
large arteries in the daily care of the general 
hypertensive population remains to be deter­
mined.
